fibrinogen has been researched along with Amyloid Deposits in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akassoglou, K; Merlini, M; Nana, AL; Seeley, WW; Sozmen, EG; Subramanian, KS | 1 |
| Ceglarz, K; Durlik, M; Gozdowska, J; Kosieradzki, M; Świder, R; Zduńczyk, D | 1 |
| Attems, J; DeCarli, C; Dey, M; Erskine, D; Graham, S; Johnson, M; Johnston, E; McAleese, KE; McKeith, IG; Thomas, AJ; Walker, L | 1 |
| Akassoglou, K; Davalos, D; Ellisman, M; Gill, TM; Merlini, M; Mucke, L; Muthukumar, G; Nelson, RB; Rafalski, VA; Rios Coronado, PE; Ryu, JK; Seeley, WW; Subramanian, KS; Syme, CA | 1 |
| Hultman, K; Norris, EH; Strickland, S | 1 |
| Gentleman, SM; Griffin, WS; Kalaitzakis, ME; Pearce, RK; Pey, P | 1 |
| Dasari, S; Dogan, A; Highsmith, WE; Kocher, JP; Kurtin, PJ; Theis, JD; Vrana, JA; Zenka, RM; Zimmermann, MT | 1 |
| Chung, YC; Feierman, E; Kruyer, A; Norris, EH; Richards, A; Strickland, S; Yao, Y | 1 |
1 review(s) available for fibrinogen and Amyloid Deposits
| Article | Year |
|---|---|
Difficulties in the Diagnosis of Fibrinogen Aα-Chain Amyloidosis-Literature Review and Case Report of a Patient After Kidney Transplantation.
Topics: Aged; Amyloidosis; Atrial Fibrillation; Fibrinogen; Humans; Kidney Transplantation; Male; Plaque, Amyloid; Proteinuria | 2023 |
7 other study(ies) available for fibrinogen and Amyloid Deposits
| Article | Year |
|---|---|
Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fibrinogen; Humans; Imaging, Three-Dimensional; Plaque, Amyloid | 2023 |
Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arteriolosclerosis; Biomarkers; Blood-Brain Barrier; Brain; Cerebral Amyloid Angiopathy; Cerebral Small Vessel Diseases; Female; Fibrinogen; Humans; Leukoencephalopathies; Male; Middle Aged; Plaque, Amyloid; tau Proteins; White Matter | 2019 |
Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; CD11b Antigen; CD18 Antigens; Cognitive Dysfunction; Dendritic Spines; Disease Models, Animal; Fibrinogen; Humans; Imaging, Three-Dimensional; Mice; Microglia; Plaque, Amyloid; Reactive Oxygen Species | 2019 |
The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apolipoprotein E4; Atherosclerosis; Blood Vessels; Brain; Cerebral Amyloid Angiopathy; Disease Progression; Female; Fibrinogen; Genotype; Humans; Immunohistochemistry; Male; Middle Aged; Plaque, Amyloid; Sex Characteristics | 2013 |
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; Calcium-Binding Proteins; Cell Count; DNA-Binding Proteins; Female; Fibrinogen; Humans; Macrophages; Male; Membrane Glycoproteins; Microfilament Proteins; Microglia; Middle Aged; Neurologic Examination; Parkinson Disease; Plaque, Amyloid; Receptors, Cell Surface; Receptors, Immunologic | 2014 |
Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.
Topics: Aged; Amyloid; Amyloidosis, Familial; Apolipoprotein A-I; Computational Biology; DNA Mutational Analysis; Female; Fibrinogen; Humans; Male; Middle Aged; Mutation; Peptides; Plaque, Amyloid; Proteins; Proteome; Proteomics; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |
Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biotinylation; Brain; Cerebral Amyloid Angiopathy; Dementia, Vascular; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hyperhomocysteinemia; Immunohistochemistry; Maze Learning; Memory; Methionine; Mice; Mice, Transgenic; Plaque, Amyloid; Protein Binding | 2016 |